Molecular and Cellular Mechanisms of M. tuberculosis and SARS-CoV-2 Infections-Unexpected Similarities of Pathogenesis and What to Expect from Co-Infection.
Anna A StarshinovaIgor KudryavtsevAnna MalkovaYulia ZinchenkoVadim KarevDmitry Anatolievich KudlayAngela GlushkovaAnastasiya Y StarshinovaJose DominguezRaquel Villar-HernándezIrina DovgalykPiotr YablonskiyPublished in: International journal of molecular sciences (2022)
Tuberculosis is still an important medical and social problem. In recent years, great strides have been made in the fight against M. tuberculosis , especially in the Russian Federation. However, the emergence of a new coronavirus infection (COVID-19) has led to the long-term isolation of the population on the one hand and to the relevance of using personal protective equipment on the other. Our knowledge regarding SARS-CoV-2-induced inflammation and tissue destruction is rapidly expanding, while our understanding of the pathology of human pulmonary tuberculosis gained through more the 100 years of research is still limited. This paper reviews the main molecular and cellular differences and similarities caused by M. tuberculosis and SARS-CoV-2 infections, as well as their critical immunological and pathomorphological features. Immune suppression caused by the SARS-CoV-2 virus may result in certain difficulties in the diagnosis and treatment of tuberculosis. Furthermore, long-term lymphopenia, hyperinflammation, lung tissue injury and imbalance in CD4+ T cell subsets associated with COVID-19 could propagate M. tuberculosis infection and disease progression.